Bioxyne signs $50 million German deal by Adam Sheldon May 12, 2026May 12, 2026 Bioxyne’s Breathe Life Sciences (BLS) has inked a two-year, $50 million supply agreement with German pharmaceutical […]
Bioxyne ‘on track’ to hit guidance after sharp revenue growth in Q3 by Steve Jones April 21, 2026April 21, 2026
Rec-style branding risks undermining the industry, warns Bioxyne CEO by Adam Sheldon March 12, 2026March 12, 2026
Bioxyne lifts FY26 guidance after margin growth in strong first half by Steve Jones February 26, 2026February 26, 2026
Bioxyne enters Central American markets with pastille supply deal by Steve Jones December 12, 2025December 12, 2025
News in brief: Legalise Cannabis ramps up criticism of Victorian government; MCA launches desktop guide for clinicians; Bioxyne secures A$1.7m for UK GMP facility by Adam Sheldon November 17, 2025February 21, 2026
Breathe Life Sciences launches Curaleaf medical inhalation device by Adam Sheldon November 3, 2025November 3, 2025
Record revenue for Bioxyne but cash deficit rises after flower investment by Steve Jones October 30, 2025November 3, 2025
